In this study, the possible role of serum sodium concentration and its changes on bone markers in hospitalized, hyponatremic patients is determined. Therefore, it is investigated whether in hospitalized, hyponatremic patients the level of carboxy-terminal collagen crosslinks (CTX) is modified by changes in plasma sodium concentration, independently from the aetiology of hyponatremia.
Study Type
OBSERVATIONAL
Enrollment
52
blood sampling for measurement of bone markers after a fasting period of at least 6 hours
Endocrinology, Diabetes and Metabolism, University Hospital Basel
Basel, Switzerland
Change in carboxy-terminal collagen crosslinks (CTX) levels
CTX level (pg/ml) and its dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
Change in plasma sodium level
serum sodium levels (milliequivalents per liter (mEq/L) and its dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
Changes in bone specific alkaline phosphatase (bAP)
bAP levels and their dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
Change in osteocalcin
Osteocalcin (ng/mL) levels and their dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
Change in procollagen type I N propeptide (PINP) (PINP) levels
PINP (ng/mL) levels and their dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
Change in sclerostin
Sclerostin (pg/ml) levels and their dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in parathyroid hormone (PTH)
PTH (pg/ml) levels and their dynamic within 10 days of hospitalization
Time frame: changes from baseline (day 1) to day 10 after inclusion in the study
Change in 25-hydroxy-vitamin D3
25-hydroxy-vitamin D3 (ng/ml) levels and their dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
Change in calcium
Calcium (mg/dl) levels and their dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
Change in phosphate levels
Phosphate(mg/dl) levels and their dynamic within 10 days of hospitalization
Time frame: baseline blood exam on day 1 after inclusion and further blood collections at day 10 (+/-3 days) or at discharge, if discharge will be earlier
Numbers of falls
telephone interview will be performed to collect data about occurrence and numbers of falls within 30 days after enrolment
Time frame: numbers of falls within 30 days after enrolment
Numbers of fractures
telephone interview will be performed to collect data about occurrence and numbers of fractures within 30 days after enrolment
Time frame: Numbers of fractures within 30 days after inclusion in the study